Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: A pilot study

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages

  Goletti, Delia ^a   Carrara, Stefania ^a   Mayanja Kizza, Harriet ^b   Baseke, Joy ^c   Mugerwa, Michael Angel ^b   Girardi, Enrico ^a   Toossi, Zahra ^b  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TBRU   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; GAMMA INTERFERON; PROTEIN RD1; UNCLASSIFIED DRUG; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; EPITOPE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PILOT STUDY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; UGANDA; ANALYTICAL EQUIPMENT; CD4 LYMPHOCYTE COUNT; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FOLLOW UP; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; VIRUS LOAD;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4 LYMPHOCYTE COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTERFERON TYPE II; MALE; MYCOBACTERIUM TUBERCULOSIS; PILOT PROJECTS; REAGENT KITS, DIAGNOSTIC; TUBERCULOSIS, PULMONARY; UGANDA; VIRAL LOAD;

EID: 40949124352     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-11     Document Type: Article

References (41)

1. Dye C Scheele S Dolin P Pathania V Raviglione MC Consensu statement Global burden of tuberculosis: Estimated incidence, prevalence and mortality by country J Am Med Ass 1999, 282:677-86 10.1001/jama.282.7.677
2. Reid A Scano F Getahun H Williams B Dye C Nunn P De Cock KM Hankins C Miller B Castro KG Raviglione MC Towards universal access to HIV prevention, treatment, care, and support: The role of tuberculosis/HIV collaboration Lancet Infect Dis 2006, 6:483-95 10.1016/ S1473-3099(06)70549-7 16870527
3. Nunn P Williams B Floyd K Dye C Elzinga G Raviglione M Tuberculosis control in the era of HIV Nat Rev Immunol 2005, 5:819-26 10.1038/nri1704 16200083
4. Global tuberculosis control Surveillance, planning, financing WHO report Geneva, World Health Organisation (WHO/HTM/TB/2005.349) 2005
5. Goletti D Weissman D Jackson RW Graham NM Vlahov D Klein RS Munsiff SS Ortona L Cauda R Fauci AS Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation J Immunol 1996, 157:1271-1278 8757635
6. Whalen C Okwera A Johnson J Vjecha M Hom D Wallis R Huebner R Mugerwa R Ellner J Predictors of survival in human immunodeficiency virus-infected patients with pulmonary tuberculosis The Makerere University-Case Western Reserve University Research Collaboration. Am J Respir Crit Care Med 1996, 153:1977-1981
7. Dheda K Udwadia ZF Huggett JF Johnson MA Rook GA Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis Curr Opin Pulm Med 2005, 11:195-202 10.1097/ 01.mcp.0000158726.13159.5e 15818179
8. Pai M Riley LW Colford JM Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: A systematic review Lancet Inf Dis 2004, 4:761-76 10.1016/S1473-3099(04)01206-X
9. Lalvani A Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy Chest 2007, 131:1898-906 10.1378/ chest.06-2471 17565023
10. Pai M Dheda K Cunningham J Scano F O'Brien R T-cell assays for the diagnosis of latent tuberculosis infection: Moving the research agenda forward Lancet Infect Dis 2007, 7:428-38 10.1016/S1473-3099(07)70086-5 17521596
11. Fleckenstein B Jung G Wiesmüller KH Quantitative analysis of peptide-MHC class II interaction Semin Immunol 1999, 11:405-416 10.1006/ smim.1999.0198 10625594
12. Rammensee H Bachmann J Emmerich NP Bachor OA Stevanoviæ S SYFPEITHI: Database for MHC ligands and peptide motifs Immunogenetics 1999, 50:213-219 10.1007/s002510050595 10602881
13. Singh H Raghava GP ProPred: Prediction of HLA-DR binding sites Bioinformatics 2001, 17:1236-1237 10.1093/bioinformatics/17.12.1236 11751237
14. Sturniolo T Bono E Ding J Raddrizzani L Tuereci O Sahin U Braxenthaler M Gallazzi F Protti MP Sinigaglia F Hammer J Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices Nat Biotechnol 1999, 17:555-561 10.1038/9858 10385319
15. Carrara S Vincenti D Petrosillo N Amicosante M Girardi E Goletti D Use of a T-cell-based assay for monitoring efficacy of anti-tuberculosis therapy Clin Infect Dis 2004, 38:754-6 10.1086/381754 14986262
16. + cells correlates with favourable outcome of tuberculosis JID 2006, 194:984-92 10.1086/507427 16960787
17. Goletti D Parracino MP Butera O Bizzoni F Casetti R Dainotto D Anzidei G Nisii C Ippolito G Poccia F Girardi E Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: A pilot study Resp Res 2007, 8:5 10.1186/ 1465-9921-8-5
18. http://www.ministerosalute.it/promozione/malattie/bollettino.jsp accessed July 23rd, 2007.
19. Vincenti D Carrara S Butera O Bizzoni F Casetti R Girardi E Goletti D Response to RD1 epitopes in HIV-infected individuals enrolled with suspected active tuberculosis: A pilot study Clin Exp Immunol 2007 DOI: 10.1111/j.1365-2249.2007.03462.x 17680823
20. Ferrara G Losi M D'Amico R Roversi P Piro R Meacci M Meccugni B Dori IM Andreani A Bergamini BM Mussini C Rumpianesi F Fabbri LM Richeldi L Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study Lancet 2006, 367:1328-1334 10.1016/S0140-6736(06)68579-6 16631911
21. Chapman AL Munkanta M Wilkinson KA Pathan AA Ewer K Ayles H Reece WH Mwinga A Godfrey-Faussett P Lalvani A Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells AIDS 2002, 16:2285-2293 10.1097/00002030-200211220-00008 12441800
22. Liebeschuetz S Bamber S Ewer K Deeks J Pathan AA Lalvani A Diagnosis of tuberculosis in South African children with a T-cell-based assay: A prospective cohort study Lancet 2004, 364:2196-203 10.1016/ S0140-6736(04)17592-2 15610806
23. Rangaka MX Wilkinson KA Seldon R Van Cutsem G Meintjes GA Morroni C Mouton P Diwakar L Connell TG Maartens G Wilkinson RJ The effect of HIV-1 infection on T cell based and skin test detection of tuberculosis infection Am J Respir Crit Care Med 2007, 175:514-20 10.1164/ rccm.200610-1439OC 17158278
24. Rangaka MX Diwakar L Seldon R van Cutsem G Meintjes GA Morroni C Mouton P Shey MS Maartens G Wilkinson KA Wilkinson RJ Clinical, Immunological, and epidemiological importance of antituberculosis T cell responses in HIV-infected africans Clin Infect Dis 2007, 44:1639-46 10.1086/518234 17516410
25. Ravn P Munk ME Andersen AB Lundgren B Lundgren JD Nielsen LN Kok-Jensen A Andersen P Weldingh K Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis Clin Diag Lab Immunol 2005, 12:491-496 10.1128/CDLI.12.4.491-496.2005
26. Goletti D Carrara S Vincenti D Saltini C Busi Rizzi E Schininà V Ippolito G Amicosante M Girardi E Accuracy of an immune diagnostic assay based on selected RD1 epitopes for active tuberculosis in a clinical setting: A pilot study Clinical Microbiology and Infection 2006, 12:544-50 10.1111/j.1469-0691.2006.01391.x
27. Taylor Z Nolan CM Blumberg HM American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America Controlling tuberculosis in the United States Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005, 54:1-81
28. Falk A O'Connor JB Pratt PC Webb WR Wier JA Wolinsky E Classification of pulmonary tuberculosis Diagnostic standards and classification of tuberculosis National Tuberculosis and Respiratory Disease Association. New York, N.Y. 1969:68-76
29. Hirsch CS Toossi Z Johnson JL Luzze H Ntambi L Peters P McHugh M Okwera A Joloba M Mugyenyi P Mugerwa RD Terebuh P Ellner JJ Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis J Infect Dis 2001, 183:779-88 10.1086/318817 11181155
30. GraphPad software Web site http://www.graphpad.com Accessed 11 August, 2007
31. Brock I Ruhwald M Lundgren B Westh H Mathiesen LR Ravn P Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon Gamma test Resp Res 2006, 7:56 10.1186/1465-9921-7-56
32. Aiken AM Hill PC Fox A McAdam KP Jackson-Sillah D Lugos MD Donkor SA Adegbola RA Brookes RH Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases BMC Infect Dis 2006, 6:66 1562425 16573826 10.1186/1471-2334-6-66
33. Nicol MP Pienaar D Wood K Eley B Wilkinson RJ Henderson H Smith L Samodien S Beatty D Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: Implications for diagnosis and monitoring of therapy Clin Infect Dis 2005, 40:1301-8 10.1086/429245 15825033
34. Lalvani A Nagvenkar P Udwadia Z Pathan AA Wilkinson KA Shastri JS Ewer K Hill AV Mehta A Rodrigues C Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians J Infect Dis 2001, 183:469-477 10.1086/318081 11133379
35. Scarpellini P Tasca S Galli L Beretta A Lazzarin A Fortis C Pool of selected peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection J Clin Microb 2004, 42:3469-74 10.1128/JCM.42.8.3469-3474.2004
36. Pai M Joshi R Bandyopadhyay M Narang P Dogra S Taksande B Kalantri S Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment Infection 2007, 35:98-103 10.1007/ s15010-007-6114-z 17401714
37. Lazarevic V Nolt D Flynn JL Long-Term Control of Mycobacterium tuberculosis Infection Is Mediated by Dynamic Immune Responses J Immunol 2005, 175:1107-17 16002712
38. D'Offizi G Montesano C Agrati C Gioia C Amicosante M Topino S Narciso P Pucillo LP Ippolito G Poccia F Expansion of pre-terminally differentiated CD8 T cells in chronic HIV-positive patients presenting a rapid viral rebound during structured treatment interruption AIDS 2002, 16:2431-8 10.1097/00002030-200212060-00008 12461417
39. + T lymphocytes with changes in viral load J Immunol 2000, 165:1692-04 10903781
40. Godkin AJ Thomas HC Openshaw PJ Evolution of Epitope-Specific Memory CD4-T Cells After Clearance of Hepatitis C Virus J Immunol 2002, 169:2210-14 12165552
41. Goletti D Carrara S Vincenti D Girardi E T cell responses to commercial M. tuberculosis-specific antigens in HIV-infected patients Clin Infect Dis 2007, 45:1652-54 10.1086/523012 18190334